by admin | Jan 30, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Miami, FL – January 30, 2017 – The international regenerative medicine community concluded a week sharing breakthroughs, facing challenges and developing collaborations at the 13th World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-26, 2018. The...
by admin | Jan 26, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 – Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill...
by admin | Jan 26, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake...
by admin | Jan 23, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit,...
by admin | Jan 22, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
by admin | Jan 22, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
